Long-term Efficacy of TNF-alpha Inhibitors on Persistent Uveitic Macular Edema: A Swiss Multicenter Cohort Study

References

• Jabs DA, Busingye J. Approach to the diagnosis of the uveitides. Am J Ophthalmol. 2013;156(2):228–236. doi:10.1016/j.ajo.2013.03.027.
   PubMed Web of Science ®Google Scholar
• Kump LI, Cervantes-Castañeda RA, Androudi SN, et al. Analysis of pediatric uveitis cases at a tertiary referral center. Ophthalmology. 2005;112(7):1287–1292. doi:10.1016/j.ophtha.2005.01.044.
   PubMed Web of Science ®Google Scholar
• Lardenoye CW, van Kooij B, Rothova A. Impact of macular edema on visual acuity in uveitis. Ophthalmology. 2006;113(8):1446–1449. doi:10.1016/j.ophtha.2006.03.027.
   PubMed Web of Science ®Google Scholar
• Guex-Crosier Y. The pathogenesis and clinical presentation of macular edema in inflammatory diseases. Doc Ophthalmol. 1999;97(3–4):297–309. doi:10.1023/A:1002130005227.
   PubMed Web of Science ®Google Scholar
• Koronis S, Stavrakas P, Balidis M, et al. Update in treatment of uveitic macular edema. Drug Des Devel Ther. 2019;13:667–680. doi:10.2147/DDDT.S166092.
   PubMed Web of Science ®Google Scholar
• Otani T, Yamaguchi Y, Kishi S. Correlation between visual acuity and foveal microstructural changes in diabetic macular edema. Retina. 2010;30(5):774–780. doi:10.1097/IAE.0b013e3181c2e0d6.
   PubMed Web of Science ®Google Scholar
• Fardeau C, Champion E, Massamba N, et al. Uveitic macular edema. Eye (Lond). 2016;30(10):1277–1292. doi:10.1038/eye.2016.115.
   PubMed Web of Science ®Google Scholar
• Majumder PD, Sudharshan S, Biswas J. Laboratory support in the diagnosis of uveitis. Indian J Ophthalmol. 2013;61(6):269–276. doi:10.4103/0301-4738.114095.
   PubMed Web of Science ®Google Scholar
• Jabs DA, Nussenblatt RB, Rosenbaum JT, et al. Standardization of uveitis nomenclature for reporting clinical data. Results of the first international workshop. Am J Ophthalmol. 2005;140(3):509–516. doi:10.1016/j.ajo.2005.03.057.
   PubMed Web of Science ®Google Scholar
• Jaffe GJ, Dick AD, Brézin AP, et al. Adalimumab in patients with active noninfectious uveitis. N Engl J Med. 2016;375(10):932–943. doi:10.1056/NEJMoa1509852.
   PubMed Web of Science ®Google Scholar
• Nguyen QD, Merrill PT, Jaffe GJ, et al. Adalimumab for prevention of uveitic flare in patients with inactive non-infectious uveitis controlled by corticosteroids (VISUAL II): a multicentre, double-masked, randomised, placebo-controlled phase 3 trial. Lancet. 2016;388(10050):1183–1192. doi:10.1016/S0140-6736(16)31339-3.
   PubMed Web of Science ®Google Scholar
• Santos Lacomba M, Marcos Martín C, Gallardo Galera JM, et al. Aqueous humor and serum tumor necrosis factor-alpha in clinical uveitis. Ophthalmic Res. 2001;33(5):251–255. doi:10.1159/000055677.
   PubMed Web of Science ®Google Scholar
• Steeples LR, Spry P, Lee RWJ, et al. Adalimumab in refractory cystoid macular edema associated with birdshot chorioretinopathy. Int Ophthalmol. 2018;38(3):1357–1362. doi:10.1007/s10792-017-0592-5.
   PubMed Web of Science ®Google Scholar
• Diaz-Llopis M, Salom D, Garcia-de-Vicuña C, et al. Treatment of refractory uveitis with Adalimumab: a prospective multicenter study of 131 patients. Ophthalmology. 2012;119(8):1575–1581. doi:10.1016/j.ophtha.2012.02.018.
   PubMed Web of Science ®Google Scholar
• Schaap-Fogler M, Amer R, Friling R, et al. Anti-TNF-alpha agents for refractory cystoid macular edema associated with noninfectious uveitis. Graefes Arch Clin Exp Ophthalmol. 2014;252(4):633–640. doi:10.1007/s00417-013-2552-8.
   PubMed Web of Science ®Google Scholar
• Wolf-Schnurrbusch UE, Ceklic L, Brinkmann CK, et al. Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments. Invest Ophthalmol Vis Sci. 2009;50(7):3432–3437. doi:10.1167/iovs.08-2970.
   PubMed Web of Science ®Google Scholar
• Roh YR, Park KH, Woo SJ. Foveal thickness between stratus and spectralis optical coherence tomography in retinal diseases. Korean J Ophthalmol. 2013;27(4):268–275. doi:10.3341/kjo.2013.27.4.268.
   PubMedGoogle Scholar
• Musca SC, Kamiejski R, Nugier A, Méot A, Er-Rafiy A, Brauer M. Data with hierarchical structure: impact of intraclass correlation and sample size on Type-I error. Front Psychol. 2011;2:Article 74. doi:10.3389/fpsyg.2011.00074.
   PubMed Web of Science ®Google Scholar
• Streiner DL, Norman GR. Correction for multiple testing: is there a resolution? Chest. 2011;140(1):16–18. doi:10.1378/chest.11-0523.
   PubMed Web of Science ®Google Scholar
• Holm S. A simple sequentially rejective multiple test procedure. Scand J Stat. 1979;6:65–70.
   Web of Science ®Google Scholar
• Lehmann EL. Generalizations of the familywise error rate. Ann Stat. 2005;33(3):1138–1154. doi:10.1214/009053605000000084.
   Web of Science ®Google Scholar
• Liu X. Methods for handling missing data. Methods Appl Longitudinal Data Anal. 2016;441–473. doi:10.1016/B978-0-12-801342-7.00014-9.
   Google Scholar
• Massa H, Pipis SY, Adewoyin T, et al. Macular edema associated with non-infectious uveitis: pathophysiology, etiology, prevalence, impact and management challenges. Clin Ophthalmol. 2019;13:1761–1777. doi:10.2147/OPTH.S180580.
   PubMed Web of Science ®Google Scholar
• Lejoyeux R, Diwo E, Vallet H, et al. INFLIXIMAB and ADALIMUMAB in Uveitic Macular Edema. Ocul Immunol Inflamm. 2018;26(7):991–996. doi:10.1080/09273948.2018.1498110.
   PubMed Web of Science ®Google Scholar
• Kunimi K, Usui Y, Asakage M, et al. Anti-TNF-alpha therapy for refractory uveitis associated with Behcet’s sydrome and sarcoidosis: a single center study of 131 patients. Ocul Immunol Inflamm. 2022;30(1):223–230. doi:10.1080/09273948.2020.1791346.
   PubMed Web of Science ®Google Scholar
• Pearce E, Sivaprasad S, Chong NV. Factors affecting reading speed in patients with diabetic macular edema treated with laser photocoagulation. PLoS One. 2014;9(9):e105696. doi:10.1371/journal.pone.0105696.
   PubMed Web of Science ®Google Scholar
• Rothova A. Inflammatory cystoid macular edema. Curr Opin Ophthalmol. 2007;18(6):487–492. doi:10.1097/ICU.0b013e3282f03d2e.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Ikeji F, Xing W, et al. Tomographic assessment of therapeutic response to uveitic macular oedema. Clin Exp Ophthalmol. 2007;35(8):719–723. doi:10.1111/j.1442-9071.2007.01577.x.
   PubMed Web of Science ®Google Scholar
• Alasil T, Keane PA, Updike JF, et al. Relationship between optical coherence tomography retinal parameters and visual acuity in diabetic macular edema. Ophthalmology. 2010;117(12):2379–2386. doi:10.1016/j.ophtha.2010.03.051.
   PubMed Web of Science ®Google Scholar
• Brar M, Yuson R, Kozak I, et al. Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina. 2010;30(3):383–389. doi:10.1097/IAE.0b013e3181cd4803.
   PubMed Web of Science ®Google Scholar
• Tran TH, de Smet MD, Bodaghi B, et al. Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol. 2008;92(7):922–927. doi:10.1136/bjo.2007.136846.
   PubMed Web of Science ®Google Scholar
• Dick AD, Rosenbaum JT, Al-Dhibi HA, et al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: Fundamentals of Care for UveitiS (FOCUS) initiative. Ophthalmology. 2018;125(5):757–773. doi:10.1016/j.ophtha.2017.11.017.
   PubMed Web of Science ®Google Scholar
• Gulati N, Forooghian F, Lieberman R, et al. Vascular endothelial growth factor inhibition in uveitis: a systematic review. Br J Ophthalmol. 2011;95(2):162–165. doi:10.1136/bjo.2009.177279.
   PubMed Web of Science ®Google Scholar
• Chaudhary KM, Mititelu M, Lieberman RM. An evidence-based review of vascular endothelial growth factor inhibition in pediatric retinal diseases: part 2. Coats’ disease, best disease, and uveitis with childhood neovascularization. J Pediatr Ophthalmol Strabismus. 2013;50(1):11–19. doi:10.3928/01913913-20120821-02.
   PubMed Web of Science ®Google Scholar
• Weiss K, Steinbrugger I, Weger M, et al. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab. Eye (Lond). 2009;23(9):1812–1818. doi:10.1038/eye.2008.388.
   PubMed Web of Science ®Google Scholar
• Wolfensberger TJ. The role of carbonic anhydrase inhibitors in the management of macular edema. Doc Ophthalmol. 1999;97(3–4):387–397. doi:10.1023/A:1002143802926.
   PubMed Web of Science ®Google Scholar
• Palla S, Biswas J, Nagesha CK. Efficacy of Ozurdex implant in treatment of noninfectious intermediate uveitis. Indian J Ophthalmol. 2015;63(10):767–770. doi:10.4103/0301-4738.171505.
   PubMed Web of Science ®Google Scholar
• Deuter CME, Zierhut M, Igney-Oertel A, et al. Tocilizumab in uveitic macular edema refractory to previous immunomodulatory treatment. Ocul Immunol Inflamm. 2017;25(2):215–220. doi:10.3109/09273948.2015.1099680.
   PubMed Web of Science ®Google Scholar
• Tappeiner C, Mesquida M, Adán A, et al. Evidence for tocilizumab as a treatment option in refractory uveitis associated with Juvenile idiopathic arthritis. J Rheumatol. 2016;43(12):2183–2188. doi:10.3899/jrheum.160231.
   PubMed Web of Science ®Google Scholar
• Lewczuk N, Zdebik A, Boguslawska J. Interferon Alpha 2a and 2b in ophthalmology: a review. J Interferon Cytokine Res. 2019;39(5):259–272. doi:10.1089/jir.2018.0125.
   PubMed Web of Science ®Google Scholar
• Mackensen F, Jakob E, Springer C, et al. Interferon versus methotrexate in intermediate uveitis with macular edema: results of a randomized controlled clinical trial. Am J Ophthalmol. 2013;156(3):478–486 e1. doi:10.1016/j.ajo.2013.05.002.
   PubMed Web of Science ®Google Scholar
• Eser-Ozturk H, Sullu Y. The results of interferon-alpha treatment in behcet uveitis. Ocul Immunol Inflamm. 2020;28(3):498–504. doi:10.1080/09273948.2019.1587473.
   PubMed Web of Science ®Google Scholar
• Suhler EB, Jaffe GJ, Fortin E, et al. Long-Term safety and efficacy of adalimumab in patients with noninfectious intermediate uveitis, posterior uveitis, or panuveitis. Ophthalmology. 2021;128(6):899–909. doi:10.1016/j.ophtha.2020.10.036.
   PubMed Web of Science ®Google Scholar
• Suhler EB, Adán A, Brézin AP, et al. Safety and efficacy of adalimumab in patients with noninfectious uveitis in an ongoing open-label study: VISUAL III. Ophthalmology. 2018;125(7):1075–1087. doi:10.1016/j.ophtha.2017.12.039.
   PubMed Web of Science ®Google Scholar
• Kruh JN, Yang P, Suelves AM, et al. Infliximab for the treatment of refractory noninfectious Uveitis: a study of 88 patients with long-term follow-up. Ophthalmology. 2014;121(1):358–364. doi:10.1016/j.ophtha.2013.07.019.
   PubMed Web of Science ®Google Scholar
• Ducourau E, Rispens T, Samain M, et al. Methotrexate effect on immunogenicity and long-term maintenance of Adalimumab in axial spondyloarthritis: a multicentric randomised trial. RMD Open. 2020;6(1):e001047. doi:10.1136/rmdopen-2019-001047.
   PubMed Web of Science ®Google Scholar
• Gharib MH, AlKahlout MA, Garcia Canibano B, et al. Demyelinating neurological adverse events following the use of anti-TNF-alpha agents: a double-edged sword. Case Rep Neurol Med. 2022;2022:3784938. doi:10.1155/2022/3784938.
   PubMed Web of Science ®Google Scholar
• Seror R, Richez C, Sordet C, et al. Pattern of demyelination occurring during anti-TNF-alpha therapy: a French national survey. Rheumatology (Oxford). 2013;52(5):868–874. doi:10.1093/rheumatology/kes375.
   PubMed Web of Science ®Google Scholar
• Tynjala P, Lindahl P, Honkanen V, et al. Infliximab and etanercept in the treatment of chronic uveitis associated with refractory juvenile idiopathic arthritis. Ann Rheum Dis. 2007;66(4):548–550. doi:10.1136/ard.2006.058248.
   PubMed Web of Science ®Google Scholar
• Quartier P, Baptiste A, Despert V, et al. ADJUVITE: a double-blind, randomised, placebo-controlled trial of Adalimumab in early onset, chronic, juvenile idiopathic arthritis-associated anterior uveitis. Ann Rheum Dis. 2018;77(7):1003–1011. doi:10.1136/annrheumdis-2017-212089.
   PubMed Web of Science ®Google Scholar
• Ramanan AV, Dick AD, Jones AP, et al. Adalimumab plus methotrexate for uveitis in Juvenile idiopathic arthritis. N Engl J Med. 2017;376(17):1637–1646. doi:10.1056/NEJMoa1614160.
   PubMed Web of Science ®Google Scholar